Farquharson CA - Search Results

1

Allopurinol improves endothelial dysfunction in chronic heart failure.

Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Farquharson CA, et al. Circulation. 2002 Jul 9;106(2):221-6. doi: 10.1161/01.cir.0000022140.61460.1d. Circulation. 2002. PMID: 12105162 Clinical Trial.

2

Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man.

Sim JS, Farquharson C, Struthers AD. Sim JS, et al. J Renin Angiotensin Aldosterone Syst. 2004 Jun;5(2):84-8. doi: 10.3317/jraas.2004.015. J Renin Angiotensin Aldosterone Syst. 2004. PMID: 15295720 Free article. Clinical Trial.

3

Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extrasystoles but does not change endothelial function or heart rate variability in chronic heart failure.

Farquharson CA, Struthers AD. Farquharson CA, et al. Heart. 2002 Nov;88(5):475-80. doi: 10.1136/heart.88.5.475. Heart. 2002. PMID: 12381637 Free PMC article. Clinical Trial.

4

Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure.

Farquharson CA, Struthers AD. Farquharson CA, et al. J Am Coll Cardiol. 2002 Mar 6;39(5):767-75. doi: 10.1016/s0735-1097(02)01689-3. J Am Coll Cardiol. 2002. PMID: 11869839 Free article. Clinical Trial.

5

Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy.

Farquharson CA, Struthers AD. Farquharson CA, et al. Clin Sci (Lond). 2002 Oct;103(4):425-31. doi: 10.1042/cs1030425. Clin Sci (Lond). 2002. PMID: 12241543 Clinical Trial.

6

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.

Farquharson CA, Struthers AD. Farquharson CA, et al. Circulation. 2000 Feb 15;101(6):594-7. doi: 10.1161/01.cir.101.6.594. Circulation. 2000. PMID: 10673249 Clinical Trial.

7

Reversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunction.

Lim PO, Tzemos N, Farquharson CA, Anderson JE, Deegan P, MacWalter RS, Struthers AD, MacDonald TM. Lim PO, et al. Among authors: farquharson ca. J Hum Hypertens. 2002 Jun;16(6):411-5. doi: 10.1038/sj.jhh.1001404. J Hum Hypertens. 2002. PMID: 12037696

8

Angiotensin II receptor blockers in chronic heart failure--not as ELITE as expected!

Farquharson CA, Struthers AD. Farquharson CA, et al. J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):21-2. doi: 10.3317/jraas.2000.003. J Renin Angiotensin Aldosterone Syst. 2000. PMID: 11967790 Free article.

9

Adverse cardiac effects of salt with fludrocortisone in hypertension.

Lim PO, Farquharson CA, Shiels P, Jung RT, Struthers AD, MacDonald TM. Lim PO, et al. Among authors: farquharson ca. Hypertension. 2001 Mar;37(3):856-61. doi: 10.1161/01.hyp.37.3.856. Hypertension. 2001. PMID: 11244008 Clinical Trial.

10

Effect of spironolactone on C-reactive protein levels in patients with heart disease.

Godfrey V, Farquharson CA, Macdonald JE, Yee KM, Struthers AD. Godfrey V, et al. Among authors: farquharson ca. Int J Cardiol. 2007 Apr 25;117(2):282-4. doi: 10.1016/j.ijcard.2006.05.069. Epub 2006 Aug 8. Int J Cardiol. 2007. PMID: 16899309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters